Kyle Amber to Pemphigus
This is a "connection" page, showing publications Kyle Amber has written about Pemphigus.
Connection Strength
9.091
-
Development of Pneumocystis pneumonia in a patient receiving both rituximab and IVIg for pemphigus vulgaris. J Dtsch Dermatol Ges. 2022 04; 20(4):520-521.
Score: 0.769
-
The Immunogenetics of Autoimmune Blistering Diseases. Adv Exp Med Biol. 2022; 1367:173-212.
Score: 0.758
-
The risk of Pneumocystis pneumonia in patients of?autoimmune blistering disease-reply to letter entitled "Pemphigus management guidelines: A life-saving perspective". J Am Acad Dermatol. 2021 11; 85(5):e289.
Score: 0.733
-
Autoreactive T cells in pemphigus: perpetrator and target. Ital J Dermatol Venerol. 2021 04; 156(2):124-133.
Score: 0.700
-
Pemphigus vulgaris manifesting as severe oral and epiglottal epithelial dysplasia. J Dtsch Dermatol Ges. 2020 Aug; 18(8):895-896.
Score: 0.688
-
IgA pemphigus: A systematic review. J Am Acad Dermatol. 2020 Jun; 82(6):1386-1392.
Score: 0.656
-
Pemphigus subtype: a confounder in determining the association of oral involvement with post-rituximab relapses. Dermatol Ther. 2019 05; 32(3):e12918.
Score: 0.629
-
Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev. 2019 May; 18(5):526-534.
Score: 0.623
-
Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris. Front Immunol. 2018; 9:1190.
Score: 0.591
-
Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes. Nat Rev Dis Primers. 2018 02 22; 4:18012.
Score: 0.580
-
The controversy of hepatitis C and rituximab: A multidisciplinary dilemma with implications for patients with pemphigus. Indian J Dermatol Venereol Leprol. 2016 Mar-Apr; 82(2):182-3.
Score: 0.505
-
Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris. Exp Dermatol. 2013 Nov; 22(11):699-704.
Score: 0.430
-
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study. Br J Dermatol. 2023 03 30; 188(4):499-505.
Score: 0.206
-
Patients with pemphigus are at an increased risk of developing rheumatoid arthritis: a large-scale cohort study. Immunol Res. 2020 12; 68(6):373-378.
Score: 0.175
-
Hidradenitis suppurativa and pemphigus: a cross-sectional study. Arch Dermatol Res. 2020 Sep; 312(7):501-505.
Score: 0.166
-
The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal Study. Front Immunol. 2019; 10:1559.
Score: 0.160
-
Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris. J Biol Chem. 2019 03 22; 294(12):4520-4528.
Score: 0.155
-
Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548.
Score: 0.151
-
Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus. Autoimmun Rev. 2018 Oct; 17(10):1002-1010.
Score: 0.150
-
Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center. J Am Acad Dermatol. 2018 04; 78(4):806-808.
Score: 0.142
-
Immune response in pemphigus and beyond: progresses and emerging concepts. Semin Immunopathol. 2016 Jan; 38(1):57-74.
Score: 0.124